Risultati della ricerca - Hiroyuki Murai
- Mostra 1 - 20 risultati su 30
- Vai alla pagina seguente
-
1
<scp>J</scp>apanese clinical guidelines for myasthenia gravis: Putting into practice di Hiroyuki Murai
Pubblicazione 2015Artigo -
2
-
3
-
4
Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis di Takuya Matsushita, Takahisa Tateishi, Noriko Isobe, Tomomi Yonekawa, Ryo Yamasaki, Dai Matsuse, Hiroyuki Murai, Jun‐ichi Kira
Pubblicazione 2013Artigo -
5
-
6
-
7
-
8
Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody–Positive Generalized Myasthenia Gravis di James F. Howard, John Vissing, Nils Erik Gilhus, Maria Isabel Leite, Kimiaki Utsugisawa, Petra W. Duda, Ramin Farzaneh‐Far, Hiroyuki Murai, Heinz Wiendl
Pubblicazione 2021Revisão -
9
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis di Takaaki Ishizu, Manabu Osoegawa, Feng-Jun Mei, Hitoshi Kikuchi, Masahito Tanaka, Yuka Takakura, Motozumi Minohara, Hiroyuki Murai, Futoshi Mihara, Takayuki Taniwaki, Jun‐ichi Kira
Pubblicazione 2005Artigo -
10
-
11
Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey di Hiroyuki Murai, Natsumi Yamashita, Makoto Watanabe, Yoshiko Nomura, Masakatsu Motomura, Hiroaki Yoshikawa, Yosikazu Nakamura, Naoki Kawaguchi, Hiroshi Onodera, Shigeru Araga, Noriko Isobe, Masaki Nagai, Jun‐ichi Kira
Pubblicazione 2011Artigo -
12
Early Detection of Abnormal Prion Protein in Genetic Human Prion Diseases Now Possible Using Real-Time QUIC Assay di Kazunori Sano, Katsuya Satoh, Ryuichiro Atarashi, Hiroshi Takashima, Yasushi Iwasaki, Mari Yoshida, Nobuo Sanjo, Hiroyuki Murai, Hidehiro Mizusawa, Matthias Schmitz, Inga Zerr, Yong-Sun Kim, Noriyuki Nishida
Pubblicazione 2013Artigo -
13
Early fast‐acting treatment strategy against generalized myasthenia gravis di Kimiaki Utsugisawa, Yuriko Nagane, Tetsuya Akaishi, Yasushi Suzuki, Tomihiro Imai, Emiko Tsuda, Naoya Minami, Akiyuki Uzawa, Naoki Kawaguchi, Masayuki Masuda, Shingo Konno, Hidekazu Suzuki, Hiroyuki Murai, Masashi Aoki
Pubblicazione 2016Artigo -
14
Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study di Yuriko Nagane, Hiroyuki Murai, Tomihiro Imai, Daisuke Yamamoto, Emiko Tsuda, Naoya Minami, Yasushi Suzuki, Tetsuya Kanai, Akiyuki Uzawa, Naoki Kawaguchi, Masayuki Masuda, Shingo Konno, Hidekazu Suzuki, Masashi Aoki, Kimiaki Utsugisawa
Pubblicazione 2017Artigo -
15
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic di Saiju Jacob, Srikanth Muppidi, Amanda C. Guidon, Jeffrey T. Guptill, Michael K. Hehir, James F. Howard, Isabel Illa, Renato Mantegazza, Hiroyuki Murai, Kimiaki Utsugisawa, John Vissing, Heinz Wiendl, Richard J. Nowak
Pubblicazione 2020Artigo -
16
Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene di Temu Qina, Nobuo Sanjo, Masaki Hizume, Maya Higuma, Makoto Tomita, Ryuichiro Atarashi, Katsuya Satoh, Ichiro Nozaki, Tsuyoshi Hamaguchi, Yosikazu Nakamura, Atsushi Kobayashi, Tetsuyuki Kitamoto, Shigeo Murayama, Hiroyuki Murai, Masahito Yamada, Hidehiro Mizusawa
Pubblicazione 2014Artigo -
17
Characterization of IgG4 anti‐neurofascin 155 antibody‐positive polyneuropathy di Hidenori Ogata, Ryo Yamasaki, Akio Hiwatashi, Nobuyuki Oka, Nobutoshi Kawamura, Dai Matsuse, Motoi Kuwahara, Hidekazu Suzuki, Susumu Kusunoki, Yuichi Fujimoto, Koji Ikezoe, Hitaru Kishida, Fumiaki Tanaka, Takuya Matsushita, Hiroyuki Murai, Jun‐ichi Kira
Pubblicazione 2015Artigo -
18
Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis di Munenori Oyama, Kensuke Okada, Masayuki Masuda, Yuko Shimizu, Kazumasa Yokoyama, Akiyuki Uzawa, Naoki Kawaguchi, Ryotaro Ikeguchi, Yasunobu Hoshino, Taku Hatano, Yukiko Ozawa, Jin Nakahara, Hitoshi Aizawa, Kazuo Kitagawa, Nobutaka Hattori, Satoshi Kuwabara, Hiroyuki Murai, Shigeaki Suzuki
Pubblicazione 2020Artigo -
19
Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan di Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Kei Ishizuchi, Daiki Tokuyasu, Hideo Handa, Manato Yasuda, Naoki Kawaguchi, Takashi Kimura, Yasushi Suzuki, Takamichi Sugimoto, Naoya Minami, Masanori Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Pubblicazione 2024Artigo -
20
International consensus guidance for management of myasthenia gravis di Donald B. Sanders, Gil I. Wolfe, Michael Benatar, Amelia Evoli, Nils Erik Gilhus, Isabel Illa, Nancy L. Kuntz, Janice M. Massey, Arthur Melms, Hiroyuki Murai, Michael Nicolle, Jacqueline Palace, David P. Richman, Jan J.G.M. Verschuuren, Pushpa Narayanaswami
Pubblicazione 2016Revisão
Strumenti per la ricerca:
Soggetti correlati
Medicine
Internal medicine
Myasthenia gravis
Immunology
Pathology
Pediatrics
Physics
Disease
Gastroenterology
Surgery
Antibody
Biology
Environmental health
Intensive care medicine
Physical therapy
Population
Adverse effect
Astrobiology
Chemistry
Complement system
Epidemiology
Gene
Incidence (geometry)
Nursing
Optics
Quality of life (healthcare)
Refractory (planetary science)
Acetylcholine receptor
Clinical trial
Eculizumab